Increase/Decrease in Cash: The total change in cash for the company over the given period.
BioLargo, Inc. (BLGO) had Increase/Decrease in Cash of $0.34M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$7.76M |
|
$-11.78M |
|
$4.36M |
|
$3.41M |
|
$22.62M |
|
$-14.86M |
|
$-0.33M |
|
$-15.19M |
|
$-15.19M |
|
$-15.19M |
|
$-15.19M |
|
$-15.19M |
|
$-15.19M |
|
$-14.86M |
|
$-14.56M |
|
306.95M |
|
306.95M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$5.11M |
|
$1.64M |
|
$3.20M |
|
$8.31M |
|
$5.06M |
|
$0.86M |
|
$1.72M |
|
$6.79M |
|
$1.53M |
|
$1.53M |
|
$1.53M |
|
317.38M |
|
| Cash Flow Statement Financials | |
$-8.30M |
|
$0.43M |
|
$8.22M |
|
$3.55M |
|
$3.88M |
|
|
Increase/Decrease in Cash |
$0.34M |
$3.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.01 |
|
-- |
|
-- |
|
0.36 |
|
1.60 |
|
43.86% |
|
-191.31% |
|
-191.31% |
|
-187.53% |
|
-195.61% |
|
-151.71% |
|
$-8.34M |
|
-- |
|
-- |
|
-- |
|
0.93 |
|
14.06 |
|
12.63 |
|
28.91 |
|
-995.35% |
|
-995.35% |
|
-182.76% |
|
-637.12% |
|
$0.00 |
|
$-0.03 |
|
$-0.03 |
|